GenomeDx Canada
Industry / private company
Location:
Vancouver,
Canada (CA)
ISNI: 000000046018813X
ROR: https://ror.org/022vy2r94
Show on Map:
Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy (2020)
Gupta S, Sonpavde G, Weight C, McGregor BA, Gupta S, Maughan BL, Wei X, et al.
Conference contribution
Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol. In press (2020)
Kamoun A, de Reyniès A, Allory Y, Sjödahl G, Robertson AG, Seiler R, Hoadley KA, et al.
Journal article, Editorial